2020 Virtual Fall Conference
ASMAC is celebrating 46 years of continuing education and we want you to join us for one of the most important important agendas we’ve ever hosted. We couldn’t need each other more than we do right now –
Mark your calendars for these dates!!
ASMAC’s first-ever virtual fall conference will be an exceptional must-attend online experience that kicks off on Friday, October 2. It’s been quite a year and now is the time to come together to feel the connections, lift each other up, and learn as much as we can to continue our important work! Session topics include: Racism and Implicit Bias in Medicine | Legal Issues Caused by COVID-19 | The Impact of COVID-19 on Physician Practices | The Pharmaceutical Industry’s Race to a Vaccine | When Pharmacies Blacklist Physician Prescriptions | Update on Physician Health Programs | Litigation Updates, and more!
Coming Soon: Conference Agenda | Speaker Biographies | Program Evaluation
ASMAC FALL CONFERENCE ALL ACCESS PASS – Best Value!
A LA CARTE REGISTRATION
Friday – October 2, 2020
Racism: A Public Health Crisis
Speakers and Facilitators:
- Francisco Silva, JD, Senior Vice President, California Medical Association
- Debra Cohn, JD, Senior Washington Counsel, American Medical Association
- Almeta Cooper, JD, Principal, The AECooper Group
- Brian Vandenberg, JD, Senior Vice President & General Counsel, American Medical Association
Description: The purpose of this session is to reinforce inclusive behavior and language and ensure that anti-discrimination, inclusion, and equal opportunity are strategic priorities for medical societies, health care, and physician workplaces. This session will include updates from several medical societies as well as an opportunity for small group discussion. Registration for this session includes a copy of the New York Times bestseller “White Fragility” by Robin DiAngelo
Saturday – October 3, 2020
Arctic Survival Teambuilding Activity (2CLE)
Human Synergistics Virtual Professional Development Program
Description: Entertaining, Social and CLE-Eligible! This is an interesting educational activity. It’s unusual for and activity to be educational, social and engaging. There’s more to this exercise than simple team building. For this challenge, you will be working in small groups to solve an age-old question – “What is most import to the group’s survival?”
Join us to learn more about your colleagues, arctic survival and the importance of the work we do together!
TUESDAY – October 13, 2020 | 12:00 PM EST
COVID-19: THE IMPACT ON PHYSICIANS AND PRACTICES (2 CLE’s)
COVID-19: LEGAL STORIES FROM THE TRENCHES
Faculty: Tom Conley, JD (Saul Ewing Arnstein & Lehr LLP), Richard Levenstein, JD (Nason Yeager Gerson Harris & Fumero, PA), Greg Pepe, JD (Neubert, Pepe & Monteith, PC)
Description: This session will focus on the legal experiences and lessons learned during the pandemic. Speakers will discuss legal issues and implications of practice issues, PPP Loans, real estate use issues caused by COVID-19.
PHYSICIAN PRACTICE TRENDS
Faculty: Emily Carroll, JD, American Medical Association, Kimberly Horvath, JD, American Medical Association, Alexis Pierce, JD, American Medical Association, Kyle Thomson, JD, American Medical Association,
Description: This session will cover important developments caused by pandemic conditions including tele-health; scope of practice, access to coverage & special enrollments, and vaccines.
TUESDAY – October 20, 2020 | 12:00 PM EST
TUESDAY – October 20, 2020 | 1:00 PM EST
WHEN PHARMACIES BLACKLIST PHYSICIANS (1 CLE)
Faculty: Daniel Blaney-Koen, JD, American Medical Association, Cassie Korando, JD, Shawnee Health Services and Development Corporation, David Porter, Illinois State Medical Society, David Steed, JD, Cornelius & Collins, LLP
Description: Following the publication in 2016 of CDC’s opioid prescribing guidelines, many state legislatures, health insurance companies, pharmacy chains and PBMs decided to enact, implement and require strict thresholds for prescriptions of opioid analgesics. While these actions all have largely embraced arbitrary thresholds and created incredible challenges for many patients with pain, there have been additional, unintended consequences.
This session will explore the use of arbitrary—and proprietary—decision-making processes by pharmacies and others to place physicians on de facto “blacklists” whereby a pharmacy informs a physician that he or she will no longer be able to have any prescriptions for a controlled substance filled by that pharmacy chain. You will hear from attorneys whose clients have received such letters, the lengths that have been undertaken to resolve the issue(s), and the impact on the physicians and their patients.